Aditxt, Inc.
corporate_fare Company Profile
Aditxt, Inc. (OTC:ADTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 44 items for ADTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-15, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 16 rated 8 or above. Recent SEC coverage for ADTX spans 8-K, 4, PRE 14A.
Recent high-impact activity:
- Aditxt's Ignite Proteomics SPAC Merger Collapses as Parties Mutually Terminate Deal
- Aditxt Confirms Nasdaq Form 25 Filing — Delisting Becomes Effective Within Days
- Aditxt Divests Pearsanta for Contingent Royalties and Milestones
- Aditxt Restructures Note Agreement, Adds New Investor Amid Nasdaq Delisting
- Nasdaq Panel Denies Aditxt's Listing Request; Trading Suspension Imminent
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 896,756 shares in ADTX as of the October 30, 2026 settlement, a 0.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 3.3% of ADTX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for ADTX, detected from its recent SEC filings · based on capital-structure filings through 2026-06-23.
Additional Capital Raise · Increased Convertible Note Debt
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →